Perforomist [formoterol] vs. foradil [formoterol] evaluated by inspiratory capacity and HRCT [high resolution computed tomography]

Trial Profile

Perforomist [formoterol] vs. foradil [formoterol] evaluated by inspiratory capacity and HRCT [high resolution computed tomography]

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 09 Aug 2016

At a glance

  • Drugs Formoterol; Formoterol
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Oct 2008 Data will be presented at the Annual International Scientific Assembely of the American College of Chest Physicians (CHEST), 2008, as reported in a media relaese from Dey.
    • 24 Sep 2008 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 31 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top